Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucrosomial Iron vs Iron Sulphate in Blood Donors
NCT05678647Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Jan 2023
- Primary completion
- Mar 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Randomised, open-label trial of sucrosomial iron in iron deficiency anemia (IDA) (2 arms), sponsored by Akademiska sjukhuset. Primary endpoint: Side effects at 1 year. Started Jan 2023; status: completed.
02
Drugs
sucrosomial iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05678647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05678647.